Cronos Group (CRON) falls short of analyst estimates
Cronos Group (CRON) currently trades at $5.85 and has fallen by 7.58% in the past 24 hours. The cannabis company posted net revenue of $7.3 million, up 41.3% from the $4.3 million posted in the similar quarter last year. The revenue was 37% lower than the FactSet analyst average estimate of $11.6 million.
Based on this information, investorsQ rates this stock 4 out of 10. We give it this rating because the diluted earnings per share for Q4 was at 16 cents, up 21 cents year-on-year from a loss of five cents per share posted in 2018 Q4. The EPS also beat the FactSet analysts estimate of a loss per share of three cents. The high forecast for Cronos Group is $12.84 and the low is $4.93. Notably, the company’s market cap is $2.08 billion with a 52 week high of $18.76 and a 52 week low of $4.00.